Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Gastroenterology|May 1, 2025
ReplyHarry Sokol, David Tougeron
La Revue Du Praticien|March 13, 2010
[Gastric tumors]David Tougeron, Pierre Michel
Translational Cancer Research|January 10, 2024
<i>KRAS</i> G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma?Marie Muller, David Tougeron
Cancers|July 2, 2021
Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging TherapiesViolaine Randrian, Camille Evrard, David Tougeron
JAMA Oncology|June 16, 2017
Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?Sheik Emambux, Guillaume Mouillet, David Tougeron
Bulletin Du Cancer|March 19, 2013
[Immune response and colorectal cancer]David Tougeron, Emilie Fauquembergue, Jean-Baptiste Latouche
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 19, 2016
Absence of IDH mutation in colorectal cancers with microsatellite instabilityDavid Tougeron, Karline Guilloteau, Lucie Karayan-Tapon
Gastroenterologie Clinique Et Biologique|January 11, 2007
[Severe varicella infection during treatment with infliximab for Crohn's disease]David Tougeron, Jacques Mauillon, Jean-Luc Tranvouez
Bulletin Du Cancer|August 7, 2013
[Immunotherapy for colorectal cancer]David Tougeron, Émilie Fauquembergue, Jean-Baptiste Latouche
Journal of Hepatology|March 6, 2012
ABCB4/MDR3 gene mutations and cholangiocarcinomasDavid Tougeron, Ginette Fotsing, Veronique Barbu, et al.
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Gastroenterology|May 1, 2025
ReplyHarry Sokol, David Tougeron
La Revue Du Praticien|March 13, 2010
[Gastric tumors]David Tougeron, Pierre Michel
Translational Cancer Research|January 10, 2024
<i>KRAS</i> G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma?Marie Muller, David Tougeron
Cancers|July 2, 2021
Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging TherapiesViolaine Randrian, Camille Evrard, David Tougeron
JAMA Oncology|June 16, 2017
Mutation in BRAF V600E: A Poor Prognostic Marker in Stage III Colon Cancers With Deficient MMR?Sheik Emambux, Guillaume Mouillet, David Tougeron
Bulletin Du Cancer|March 19, 2013
[Immune response and colorectal cancer]David Tougeron, Emilie Fauquembergue, Jean-Baptiste Latouche
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 19, 2016
Absence of IDH mutation in colorectal cancers with microsatellite instabilityDavid Tougeron, Karline Guilloteau, Lucie Karayan-Tapon
Gastroenterologie Clinique Et Biologique|January 11, 2007
[Severe varicella infection during treatment with infliximab for Crohn's disease]David Tougeron, Jacques Mauillon, Jean-Luc Tranvouez
Bulletin Du Cancer|August 7, 2013
[Immunotherapy for colorectal cancer]David Tougeron, Émilie Fauquembergue, Jean-Baptiste Latouche
Journal of Hepatology|March 6, 2012
ABCB4/MDR3 gene mutations and cholangiocarcinomasDavid Tougeron, Ginette Fotsing, Veronique Barbu, et al.
Pageof 24